Dodge & Cox Stock Fund Medtronic PLC transactions over time
MDT
Medtronic PLC historical holders
total: 14
Transactions details
- Total transactions:
- 11
- New positions:
- 1
- Added:
- 6
- Reduced:
- 4
- Held since:
- 2019 Q3
- Held for:
- 28 quarters
- Latest activity:
- 2024 Q4
Dodge & Cox Stock Fund has been an institutional investor in Medtronic PLC (MDT) since 2019 Q3. According to 2026 Q2 report, Dodge & Cox Stock Fund holds 5,743,900 shares with a market value of roughly $449.35M representing 0.38% of their equity portfolio. The fund/company first acquired MDT in 2019 Q3, initially purchasing about 4.11M shares. Since the initial investment, Dodge & Cox Stock Fund has made 10 more transactions in this position.
Does Dodge & Cox Stock Fund still hold MDT?
Yes, Dodge & Cox Stock Fund continues to hold Medtronic PLC (MDT). According to their 2026 Q2 report, they maintain a position of 5,743,900 shares valued at approximately $449.35M, representing 0.38% of their equity portfolio.
When did Dodge & Cox Stock Fund first invest in MDT?
Dodge & Cox Stock Fund first invested in Medtronic PLC (MDT) in 2019 Q3 at the reported quarter-end price of $108.62 per share, acquiring 4,110,000 shares in their initial purchase.
What is Dodge & Cox Stock Fund's average cost basis for MDT?
Based on historical transaction data, Dodge & Cox Stock Fund's estimated cost basis for Medtronic PLC (MDT) is approximately $97.23 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $97.23
- Weighted AVG sell price:
- $106.58
MDT transactions history by Dodge & Cox Stock Fund
11 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q4
|
0.41%
|
5,743,900
|
$79.88
|
$458,822,732
|
+13.09% (+664,800)
|
+0.05%
|
|
2023 Q3
|
0.43%
|
5,079,100
|
$78.36
|
$397,998,276
|
+0.53% (+26,800)
|
+0%
|
|
2023 Q2
|
0.48%
|
5,052,300
|
$88.10
|
$445,107,630
|
+0.38% (+19,000)
|
+0%
|
|
2023 Q1
|
0.46%
|
5,033,300
|
$80.62
|
$405,784,646
|
+64.70% (+1,977,300)
|
+0.18%
|
|
2022 Q3
|
0.31%
|
3,056,000
|
$80.75
|
$246,772,000
|
+0.16% (+5,000)
|
+0%
|
|
2021 Q1
|
0.44%
|
3,051,000
|
$118.13
|
$360,414,630
|
-2.68% (-83,900)
|
-0.01%
|
|
2020 Q4
|
0.52%
|
$117.14
|
-0.16% (-5,100)
|
|||
|
2020 Q2
|
0.48%
|
$91.70
|
+10.49% (+298,100)
|
|||
|
2020 Q1
|
0.50%
|
$90.18
|
-12.83% (-418,100)
|
|||
|
2019 Q4
|
0.50%
|
$113.45
|
-20.68% (-850,000)
|
|||
|
2019 Q3
|
0.65%
|
$108.62
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.